Scholars Central

Research articlePublished 15 Jun 2017

Improved radiotherapy by survivin small hairpin RNA trigger apoptosis of human lung adenocarcinoma via caspase-3 upregulation in vitro and in vivo

Authors: Chang-Feng Li, Yue Wang, Xin-Ying Li, Jing-Peng Jin, Bin Zhang, Dan-Dan Li

Biomedical Research

Volume 28 · Issue 11 · Pages 4812–4818

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Purpose: RNA interference (RNAi) of survivin gene can induce cancer apoptosis. In the current study, combined survivin shRNA (small hairpin RNA) and radiotherapy is expected to enhance the efficacy of radiotherapy in human lung cancer in vitro and in vivo. Methods: The pGenesil2 expression vectors containing survivin shRNAs was used to transfect A549 human lung adenocarcinoma cells and nude mouse grafts, followed by 5 Gy X-rays radiation. The MTT assay was performed to determine cell proliferation. Flow cytometry was used to detect the apoptosis of A549 cells. Tumor volumes were measured. Quantitative real-time PCR and Western blotting were performed to detect both mRNA and protein levels of survivin and caspase-3 in both A549 cells and nude mouse grafts. Results: A549 cell proliferation and nude mouse grafts were inhibited in the shRNA alone, 5 Gy alone and shRNA+5 Gy groups, in particular the shRNA+5 Gy group. Apoptotic percentage increased in the 5 Gy, shRNA and shRNA+5 Gy groups, in particular the shRNA+5 Gy group. Survivin mRNA and protein levels in both A549 cells and nude mouse grafts decreased in the shRNA alone and shRNA+5 Gy groups. Caspase-3 protein in both A549 cells and nude mouse grafts increased in the shRNA alone, 5 Gy alone and shRNA+5 Gy groups, in particular the shRNA+5 Gy group. Conclusion: Combined survivin shRNA and X-ray radiation can enhance the efficacy of radiotherapy by promoting the apoptosis of lung adenocarcinoma via upregulation of caspase-3 in vitro and in vivo. Combined survivin-targeted genotherapy and radiotherapy may be a potential strategy for treating lung cancer.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Biomedical Research.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalBiomedical Research
  • SubjectPathology & Lab Medicine
  • BylineArticles whose byline prints “Chang-Feng Li”
  • BylineArticles whose byline prints “Yue Wang”
  • BylineArticles whose byline prints “Xin-Ying Li”
  • BylineArticles whose byline prints “Jing-Peng Jin”
  • BylineArticles whose byline prints “Bin Zhang”
  • BylineArticles whose byline prints “Dan-Dan Li”